Sana Biotechnology, Inc. (SANA) DCF Valuation

Sana Biotechnology, Inc. (SANA) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Sana Biotechnology, Inc. (SANA) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Simplify Sana Biotechnology, Inc. (SANA) valuation with this customizable DCF Calculator! Featuring real Sana Biotechnology, Inc. (SANA) financials and adjustable forecast inputs, you can test scenarios and uncover Sana Biotechnology, Inc. (SANA) fair value in minutes.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -138.9 -287.0 -356.9 -256.9 -252.4 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation 3.9 10.2 17.9 27.7 30.9 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -142.8 -297.2 -374.8 -284.7 -283.3 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 139.0 412.0 746.9 434.0 205.2 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable .0 2.3 2.2 2.9 4.1 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure -26.2 -23.9 -29.9 -20.9 -20.0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -135.0 -290.3 -362.5 -281.4 -283.3 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -157.3 -301.7 -374.4 -273.9 -271.2 -4.1 .0 .0 .0 .0
WACC, % 9.5 9.53 9.52 9.55 9.56 9.53 9.53 9.53 9.53 9.53
PV UFCF
SUM PV UFCF -3.8
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -4
Net Debt -29
Equity Value 26
Diluted Shares Outstanding, MM 195
Equity Value Per Share 0.13

What You Will Get

  • Real SANA Financial Data: Pre-filled with Sana Biotechnology’s historical and projected data for precise analysis.
  • Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
  • Automatic Calculations: See Sana Biotechnology’s intrinsic value update instantly based on your changes.
  • Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
  • User-Friendly Design: Simple structure and clear instructions for all experience levels.

Key Features

  • Comprehensive Financial Data: Access reliable pre-loaded historical figures and future forecasts for Sana Biotechnology, Inc. (SANA).
  • Adjustable Forecast Assumptions: Modify highlighted cells for key metrics such as WACC, growth rates, and profit margins.
  • Real-Time Calculations: Automatic updates for DCF, Net Present Value (NPV), and cash flow assessments.
  • Interactive Dashboard: User-friendly charts and summaries to help visualize your investment analysis.
  • Designed for All Skill Levels: A straightforward, intuitive layout tailored for investors, CFOs, and consultants alike.

How It Works

  • Step 1: Download the prebuilt Excel template containing Sana Biotechnology’s (SANA) data.
  • Step 2: Review the pre-filled sheets to familiarize yourself with the essential metrics.
  • Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
  • Step 4: Instantly observe recalculated results, including Sana Biotechnology’s intrinsic value.
  • Step 5: Make informed investment choices or create reports based on the generated outputs.

Why Choose Sana Biotechnology, Inc. (SANA)?

  • Innovative Solutions: Cutting-edge biotechnology advancements to address unmet medical needs.
  • Expert Team: A dedicated team of scientists and industry leaders driving research and development.
  • Robust Pipeline: A diverse portfolio of therapies targeting various diseases and conditions.
  • Commitment to Quality: Stringent quality control measures ensure the highest standards in our products.
  • Investing in the Future: Focused on long-term growth and sustainable practices in biotechnology.

Who Should Use Sana Biotechnology, Inc. (SANA)?

  • Investors: Make informed investment choices with cutting-edge biotechnological insights.
  • Research Analysts: Streamline your analysis with comprehensive data on innovative therapies.
  • Consultants: Tailor the information for impactful client briefings or strategic reports.
  • Biotech Enthusiasts: Enhance your knowledge of biotechnology advancements through real-case studies.
  • Educators and Students: Utilize it as a hands-on resource in life sciences and biotechnology courses.

What the Template Contains

  • Preloaded SANA Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
  • Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
  • Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
  • Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
  • Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.

No products were found matching.